Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India

• Main Authors: Hitt J Sharma (Author), Sameer Parekh (Author), Pramod Pujari (Author), Sunil Shewale (Author), Shivani Desai (Author), Anand Kawade (Author), Mandyam Ravi (Author), Jitendra Oswal (Author), Saji James (Author), N. Mahantashetti (Author), Renuka Munshi (Author), Apurba Ghosh (Author), Venkateshwar Rao (Author), Sundaram Balsubramaniam (Author), P. Varughese (Author), A. Somshekhar (Author), Amy Sarah Ginsburg (Author), Harish Rao (Author), Manish Gautam (Author), Sunil Gairola (Author), Umesh Shaligram (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background This study assessed safety and immunogenicity of Serum Institute of India Pvt Ltd (SIIPL)'s tetanus toxoid (TT), diphtheria toxoid (DT), and acellular pertussis booster vaccine (Tdap). Research Design and Methods In this Phase II/III, multicenter, randomized, active-controlled, open-...